SCHEMBL29393705

SCHEMBL29393705

Nc1nc2c(ncn2[C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OC3O[C@@H](CO)[C@@H](O)[C@@H](O)[C@@H]3O)[C@@H](O)[C@H]2O)c(=O)[nH]1

nearest known ligand 0.73

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
FUT5 Q11128 1/20 0.73
TGM2 P21980 1/20 0.71
KRAS P01116 2/20 0.67
NT5E P21589 1/20 0.67
P2RY6 Q15077 7/20 0.63
P2RY2 P41231 6/20 0.63
P2RY4 P51582 5/20 0.63
P2RX3 P56373 1/20 0.62
P2RY14 Q15391 6/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29375573 1.00 FUT5 (0.73) FUT5TGM2KRASNT5EP2RY6
SCHEMBL29527687 1.00 FUT5 (0.73) FUT5TGM2KRASNT5EP2RY6
SCHEMBL30646153 1.00 FUT5 (0.73) FUT5TGM2KRASNT5EP2RY6
SCHEMBL29456613 1.00 FUT5 (0.73) FUT5TGM2KRASNT5EP2RY6
SCHEMBL30973673 1.00 FUT5 (0.73) FUT5TGM2KRASNT5EP2RY6
SCHEMBL29351374 1.00 FUT5 (0.73) FUT5TGM2KRASNT5EP2RY6
SCHEMBL29581866 1.00 FUT5 (0.73) FUT5TGM2KRASNT5EP2RY6
SCHEMBL29391942 1.00 FUT5 (0.73) FUT5TGM2KRASNT5EP2RY6
SCHEMBL29368655 0.99 FUT5 (0.72) FUT5TGM2KRASNT5EP2RY6
SCHEMBL25899459 0.94 FUT5 (0.73) FUT5TGM2KRASNT5EP2RY6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240093255-A1 BIOSYNTHETIC PRODUCTION OF 2-FUCOSYLLACTOSE CONAGEN INC. (US) 2024-03-21 US claimed
EP-4200318-A2 BIOSYNTHETIC PRODUCTION OF 2-FUCOSYLLACTOSE Conagen Inc. (US) 2023-06-28 EP claimed
WO-2022040411-A2 BIOSYNTHETIC PRODUCTION OF 2-FUCOSYLLACTOSE CONAGEN INC. (US) 2022-02-24 WO claimed
US-20260049329-A1 UORF::REPORTER GENE FUSIONS TO SELECT SEQUENCE CHANGES TO GENE EDIT INTO UORFS TO REGULATE ASCORBATE GENES HELLENS ROGER PAUL (NZ) 2026-02-19 US disclosed
WO-2025236045-A1 REGULATION OF GENE EXPRESSION THE UNIVERSITY OF MELBOURNE (AU) 2025-11-20 WO disclosed
US-20250154519-A1 REGULATION OF GENE EXPRESSION THE NEW ZEALAND INSTITUTE FOR PLANT AND FOOD RESEARCH LIMITED (NZ) 2025-05-15 US disclosed
CN-119530286-A Application of citrus CsGGP gene in improvement of citrus canker resistance and citrus resistance breeding 西部(重庆)科学城种质创制大科学中心 2025-02-28 CN disclosed
US-12180494-B2 Method of improving chloroplast function and increasing seed yield Arkansas State University—Jonesboro (US) 2024-12-31 US disclosed
CN-119173634-A Regulation of gene expression 新西兰植物与食品研究所 2024-12-20 CN disclosed
CN-116569923-B Low-molecular organic carbon biological hormone and application thereof 中国科学院沈阳应用生态研究所 2024-11-26 CN disclosed
CN-118910308-A Molecular marker related to ascorbic acid content of tomato fruits and application thereof 华中农业大学 2024-11-08 CN disclosed
CN-107164291-B Method for constructing and producing vitamin C escherichia coli strain by utilizing plant vitamin C synthesis way 上海市农业科学院 2022-11-29 CN disclosed
WO-2022221541-A2 METHOD FOR TERRESTRIAL CARBON SEQUESTRATION COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2022-10-20 WO disclosed
CN-115058403-A Method for increasing content of vitamin C in potato blocks 云南师范大学 2022-09-16 CN disclosed
CN-115029359-A Improvement method considering both crop yield and quality 云南师范大学 2022-09-09 CN disclosed
US-11384135-B2 Recombinant yeast strains MODERN MEADOW, INC. (US) 2022-07-12 US disclosed
CN-113293162-B Method for increasing content of vitamin C in plant 山东舜丰生物科技有限公司 2022-04-01 CN disclosed
CN-110511272-B Corn ZmbHLH55 transcription factor and application thereof 南通大学 2022-04-01 CN disclosed
WO-2022040411-A2 BIOSYNTHETIC PRODUCTION OF 2-FUCOSYLLACTOSE CONAGEN INC. (US) 2022-02-24 WO disclosed
US-20220056464-A1 METHOD OF IMPROVING CHLOROPLAST FUNCTION AND INCREASING SEED YIELD Arkansas State University - Jonesboro 2022-02-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260049329-A1 UORF::REPORTER GENE FUSIONS TO SELECT SEQUENCE CHANGES TO GENE EDIT INTO UORFS TO REGULATE ASCORBATE GENES UPF1, RNGTT, NUDT21 FUT5 3101/4885TGM2 366/4885KRAS 3408/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.